# Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

> clinical trial · VERIFIED · 2026-07-24

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Malignancy, Hematologic

- Company: National Cancer Institute (NCI)
- Sector: Malignancy, Hematologic
- Primary source: https://clinicaltrials.gov/study/NCT06904066

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.